๐ฐ Phase 3 News
Page 3 - Phase 3 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phase 3. Real-time updates on events, politics, business and more.
April 11, 2024
India News: The filing of nominations for the third phase of the 2024 general elections will begin on Friday, the Election Commission said. "Nominations for the t
March 11, 2024
This interview at AAD featured a discussion with Silverberg on nemolizumabโs efficacy and safety at Week 48 among patients with moderate-to-severe atopic dermatitis.
February 13, 2024
The findings in a recent phase 3 clinical study may allow Kalvista Pharma to seek FDA approval for this potential hereditary angioedema treatment option.
January 7, 2024
A spot check at the Ronald Ngara college found machinery on site as workers rush to complete the project.
December 21, 2023
A novel TB vaccine candidate that could replace the bacille Calmette-Guerin vaccine and has been found to provide significantly better protection against the TB germ in South African newborns, is set to reach a new benchmark in the new year as it will be tested on teenagers and adults with latent TB.
December 18, 2023
Biosenic, a company specializing in serious autoimmune and inflammatory diseases and cell therapy, has secured funding from Singapore-based TrialCap, in a bid to accelerate its phase 3 clinical development.
December 18, 2023
Shares of Invivyd, Inc. (IVVD) are up 148% on Monday following the announcement of positive initial results from the CANOPY Phase 3 pivotal clinical trial of VYD222.
December 12, 2023
Phase 3 data presented at ASH 2023 show the gene therapy significantly reduced annualized bleeding rates and the number of total bleeds.
December 12, 2023
Biosenic, a company specializing in serious autoimmune and inflammatory diseases and cell therapy, has secured funding from Singapore-based TrialCap, in a bid to accelerate its phase 3 clinical development.
December 11, 2023
Results showed treatment with iptacopan through 48 weeks caused hemoglobin-level increases, blood transfusion avoidance, and reductions in patient-reported fatigue.